The relationships of vigorous exercise, alcohol, and adiposity to low and high high-density lipoprotein-cholesterol levels

Metabolism: Clinical and Experimental

Volumn 53, Issue 6, 2004, Pages 700-709

  Williams, Paul T ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; HYPOTHESIS; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RUNNING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADIPOSE TISSUE; ALCOHOL DRINKING; BODY CONSTITUTION; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; EXERCISE; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MEDICAL RECORDS; RUNNING; SEX FACTORS; STATISTICAL DISTRIBUTIONS; WEIGHT LOSS;

EID: 3042812828     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.01.004     Document Type: Article

References (49)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III) Final Report. Circulation. 106:2002;3143-3421
2. Dreon D.M., Krauss R.M. Alcohol, lipids, and lipoproteins. Zakhari S., Wassef M. Alcohol and the Cardiovascular System. 1996;369-391. Bethesda, MD, National Institute on Alcohol Abuse and Alcoholism Research Monograph 31, NIH Publication 96-4133
3. Ioannidis J.P., Lau J. The impact of high-risk patients on the results of clinical trials. J Clin Epidemiol. 50:1997;1089-1098
4. Heizmann C., Kirchgessner T., Kwiterovich P.O., et al. DNA polymorphism haplotypes of the human lipoprotein lipase gene Possible association with high density lipoprotein levels. Hum Genet. 86:1991;578-584
5. Cohen J.C., Wang Z., Grundy S.M., et al. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest. 94:1994;2377-2384
6. Kuivenhoven J.A., Hovingh G.K., van Tol A., et al. Heterozygosity for ABCA1 gene mutations Effects on enzymes, apolipoproteins and lipoprotein particle size. Atherosclerosis. 171:2003;311-319
7. Wilund K.R., Ferrell R.E., Phares D.A., et al. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism. 51:2002;774-778
8. Hagberg J.M., Ferrell R.E., Katzel L.I., et al. Apolipoprotein E genotype and exercise training-induced increases in plasma HDL- and HDL2-cholesterol levels. Metabolism. 48:1998;943-945
9. Halverstadt A., Phares D.A., Ferrell R.E., et al. High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype. Metabolism. 52:2003;1505-1511
10. Williams P.T. Relationship of distance run per week to coronary heart disease risk factors in 8, 283 male runners. The National Runners' Health Study. Arch Intern Med. 157:1997;191-198
11. Williams P.T. High density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med. 334:1996;1298-1303
12. Folsom A.R., Casperson C.J., Taylor H.J., et al. Leisure time physical activity and its relationship to coronary risk factors in a population based sample. Am J Epidemiol. 121:1984;570-580
13. Yasim S. Measuring habitual leisure-time physical activity by recall record questionnaire. Karvonen M.J., Barry A.J. Physical Activity and the Heart. 1967;372-373 Thomas, Springfield, MO
14. Ainsworth B.E., Jacobs D.R. Jr, Leon A.S. Validity and reliability of self-reported physical activity status The Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 25:1993;92-98
15. Fuller W.A. Measurement Error Models. 1987;4 Wiley, New York, NY
16. Haskell W.L., Camargo C. Jr, Williams P.T., et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density lipoprotein subfractions. A controlled study. N Engl J Med. 310:1984;805-810
17. Williams P.T. Vigorous exercise and the population distribution of body weight. Int J Obes Relat Metab Disord. 28:2004;120-128
18. Williams PT: Relationship of adiposity to the population distribution of plasma triglyceride concentrations in vigorously active men and women. Atherosclerosis (in press)
19. Efron B. The jackknife, the bootstrap and other resampling plans. 1982;1-92 Society for Industrial and Applied Mathematics, Philadelphia, PA
20. Wilk M.B., Gnanadesikan R. Probability plotting methods for data analysis. Biometrika. 55:1968;1-17
21. Streja L., Packard C.J., Shepherd J., et al. Factors affecting low-densit lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS). Am J Cardiol. 90:2002;731-736
22. Talmud P.J., Hawe E., Robertson K., et al. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann Hum Genet. 66:2002;111-124
23. Cohen J.C., Wang Z., Grundy S.M., et al. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest. 94:1994;2377-2384
24. Lewis G.F., Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus review. Diabetes Metab Rev. 12:1996;37-56
25. Eisenberg S. High density lipoprotein metabolism. J Lipid Res. 25:1984;1017-1058
26. Brinton E.A., Eisenberg S., Breslow J.L. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb Vasc Biol. 14:1994;707-720
27. Rashid S., Uffelman K.D., Lewis G.F. The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. J Diabetes Complications. 16:2002;24-28
28. Wood P.D., Stefanick M.L., Williams P.T., et al. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 325:1991;461-466
29. Wood P.D., Stefanick M.L., Dreon D.M., et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 319:1988;1173-1179
30. Williams P.T., Stefanick M.L., Vranizan K.M., et al. The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline. Metabolism. 43:1994;917-924
31. US Department of Health and Human Services. Physical Activity and Health A report of the Surgeon General. 1996;US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA
32. Williams P.T., Wood P.D., Haskell W.L., et al. The effects of running mileage and duration on plasma lipoprotein levels. JAMA. 247:1982;2674-2679
33. Williams P.T. High density lipoproteins and lipase activity in runners. Atheriosclerosis. 98:1993;251-254
34. Zmuda J.M., Yurgalevitch S.M., Flynn M.M., et al. Exercise training has little effect on HDL levels and metabolism in men with initially low HDL cholesterol. Atherosclerosis. 137:1998;215-221
35. Couillard C., Després J.P., Lamarche B., et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides. Evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol. 21:2001;1226-1232
36. Stefanick M.L., Mackey S., Sheehan M., et al. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med. 339:1998;12-20
37. Williams P.T. Weight set-point theory and the high-density lipoprotein concentrations of long-distance runners. Metabolism. 39:1990;460-467
38. Lamon-Fava S., Wilson W.F., Schaefer E.J. Impact of body mass index on coronary heart disease risk factors in men and women The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 16:1996;1509-1515
39. Dattilo A.M., Kris-Etherton P.M. Effects of weight reduction on blood lipids and lipoproteins A meta-analysis. Am J Clin Nutr. 56:1992;320-328
40. Katzel L.I., Coon P.J., Rogus E., et al. Persistence of low HDL-C levels after weight reduction in older men with small LDL particles. Arterioscler Thromb Vasc Biol. 15:1995;299-305
41. Wing R.R., Jeffery R.W. Effect of modest weight loss on changesin cardiovascular risk factors Are there differences between men and women or between weight loss and maintenance? Int J Obes Relat Metab Disord. 19:1995;67-73
42. Marckmann P., Toubro S., Astrup A. Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects. Eur J Clin Nutr. 52:1998;329-333
43. Rimm E.B., Williams P., Fosher K., et al. Moderate alcohol intake and lower risk of coronary heart disease A meta-analysis of effects on lipids and haemostatic factors. BMJ. 319:1999;1523-1528
44. Sijbrands E.J.G., Smeltb A.H.M. Alcohol consumption had no beneficial effect on serum lipids in a substantial proportion of patients with primary hyperlipidemia. J Clin Epidemiol. 53:2000;1020-1024
45. Clevidence B.A., Reichman M.E., Judd J.T., et al. Effects of alcohol consumption on lipoproteins of premenopausal women. A controlled diet study. Arterioscler Thromb Vasc Biol. 15:1995;179-184
46. Fuller W.A. Measurement Error Models. 1987;1-99 Wiley, New York, NY
47. Rubins H.B., Robins S.J., Collins D., et al. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 341:1999;410-418
48. Frick M.H., Elo M.O., Haapa K., et al. Helsinki Heart Study Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 317:1987;1237-1245
49. Frick M.H., Syvanne M., Nieminen M.S., et al. Lopid Coronary Angiography Trial (LOCAT) Study Group. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation. 96:1997;2137-2143